Trial Profile

A prospective, multicenter and cohort study on avoid recurrence in adenomyosis after conservative surgery using various drugs

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Triptorelin (Primary)
Indications Adenomyosis; Uterine cancer
Focus Therapeutic Use

Most Recent Events

20 Jan 2020 Planned number of patients changed from 1128 to 380.
28 Jul 2018 Planned number of patients changed from 400 to 1128.
28 Jul 2018 Planned End Date changed from 30 Sep 2020 to 22 May 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com